NovaBridge Biosciences (NBP) Change in Working Capital (2023 - 2025)

NovaBridge Biosciences (NBP) has 3 years of Change in Working Capital data on file, last reported at -$198000.0 in Q2 2025.

• Quarterly Change in Working Capital rose 98.99% year-over-year to -$198000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$198000.0 (up 98.99% YoY) and the FY2024 annual result came in at -$2.8 million, up 92.43% from the prior year.
• Change in Working Capital rose to -$198000.0 in Q2 2025 per NBP's latest filing, from -$2.8 million in the prior quarter.
• Across five years, Change in Working Capital topped out at -$198000.0 in Q2 2025 and bottomed at -$37.1 million in Q4 2023.
• The 3-year median for Change in Working Capital is -$11.2 million (2024), against an average of -$15.0 million.
• The widest annual swing landed in 2024, when Change in Working Capital surged 92.43%; it then jumped 98.99% in 2025.
• Tracing NBP's Change in Working Capital over 3 years: stood at -$37.1 million in 2023, then surged by 92.43% to -$2.8 million in 2024, then soared by 92.96% to -$198000.0 in 2025.
• Per Business Quant, the three latest NBP Change in Working Capital figures stand at -$198000.0 (Q2 2025), -$2.8 million (Q4 2024), and -$19.7 million (Q2 2024).

Peer Comparison